基于因子分析法的医药制造类上市公司企业绩效实证研究  

Empirical Study Based on Factor Analysis of Enterprise Performance of Pharmaceutical Manufacturing Listed Companies

作　　者：赵晓鸽[1] 江鑫[1] 

机构地区：[1]湖南科技大学商学院,湖南湘潭411201

出　　处：《洛阳理工学院学报（社会科学版）》2017年第1期29-35,41,共8页Journal of Luoyang Institute of Science and Technology：Social Science Edition

基　　金：国家社会科学基金"全球分工背景下中小企业国际化成长机制及模式研究"资助项目(编号:11BGL007);湖南省研究生科研创新基金项目"农村劳动力永久性转移对土地流转的作用机制研究--基于分工理论的视角"资助项目(编号:CX2016B508)

摘　　要：对于一个企业来说,一个公正规范的企业绩效评价体系是至关重要的。鉴于衡量企业绩效的评价指标错综复杂,使用Stata 13.0对我国40家医药制造类上市公司2014年的财务数据进行处理,基于因子分析法对其企业绩效进行实证研究。研究结果表明:财务管理能力是影响企业绩效的主导因素;同时也发现,我国医药制造类企业的企业绩效整体偏低,有很大的提升空间,需引起企业管理者的重视。So far as an enterprise is concerned, a set of fair and normative assessing system for enterprise perform- ance is of vital importance. Given the measure of enterprise performance evaluation index is complicated, this arti- cle, based on factor analysis method for empirical research on the enterprise performance, uses Stata13.0 to process the financial data of 40 Chinese pharmaceutical manufacturing listed companies in 2014. The empirical re- suits show that the financial managerial ability is the dominant factor to affect enterprise performance. At the same time, it is found that the overall corporative performance of pharmaceutical manufacturing enterprises in our country is low and there is a lot of room to be improved, the situation of which needs urgently to he drawn attention to by the executives.

关 键 词：因子分析法 企业绩效 医药制造 

分 类 号：F224.0[经济管理—国民经济]